During the past decade, Secretaria de Saúde do Distrito Federal conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Secretaria de Saúde do Distrito Federal" #1 collaborator was "JBS/CNPq" with 1 trials as a collaborator and "University of Brasilia" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Secretaria de Saúde do Distrito Federal" are "Covid19" (2 trials), "Exercise" (1 trials), "Mechanical Ventilation Complication" (1 trials) and "Muscle Weakness Condition" (1 trials). Many other conditions were trialed in "Secretaria de Saúde do Distrito Federal" in a lesser frequency.

Most popular intervention types in "Secretaria de Saúde do Distrito Federal" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "inspiratory muscle traiing" (1 trials) and "neuromuscular electrical stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Secretaria de Saúde do Distrito Federal" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Secretaria de Saúde do Distrito Federal". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Secretaria de Saúde do Distrito Federal, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Secretaria de Saúde do Distrito Federal, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".